AZD6234
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
AstraZeneca · Phase 1 · Not yet recruiting · Enrollment 60
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Regimen A | n/r | n/r | n/r | n/r |
| Regimen B | n/r | n/r | n/r | n/r |
| Regimen C | n/r | n/r | n/r | n/r |
| Regimen D | n/r | n/r | n/r | n/r |
| Regimen E | n/r | n/r | n/r | n/r |
Not shown
- Regimen A: endpoint not reported
- Regimen B: endpoint not reported
- Regimen C: endpoint not reported
- Regimen D: endpoint not reported
- Regimen E: endpoint not reported